Desmoid fibromatosis in a child with DICER1-related tumor predisposition

Paul Scott Thorner1, Anne-Laure Chong2,3, Sung Mi Jung4

  • 1Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.

Insights

DICER1 tumor predisposition, a rare inherited disorder, can manifest as desmoid fibromatosis in children. This case highlights a DICER1 variant and CTNNB1 mutation, suggesting a synergistic pathway in tumor development.

Area of Science:

  • Genetics
  • Oncology
  • Molecular Biology

Background:

  • DICER1-related tumor predisposition is an inherited disorder typically presenting with mesenchymal tumors in children.
  • Desmoid fibromatosis involves β-catenin dysregulation, often due to APC or CTNNB1 mutations, activating the WNT pathway.

Purpose of the Study:

  • To report a unique case of chest wall desmoid fibromatosis in a child with a germline DICER1 hotspot variant.
  • To investigate the potential synergistic mechanism between DICER1 variants and CTNNB1 mutations in desmoid fibromatosis development.

Main Methods:

  • Case report of a pediatric patient with desmoid fibromatosis.
  • Genetic analysis including germline DICER1 variant and somatic CTNNB1 mutation detection.
  • Immunohistochemistry for β-catenin nuclear accumulation.

Main Results:

  • The patient had a germline DICER1 hotspot variant and a somatic CTNNB1 hotspot mutation (c.134C>T, p.S45F) in the desmoid fibromatosis.
  • Immunohistochemistry revealed β-catenin nuclear accumulation in the tumor.
  • This suggests a mechanism similar to DICER1-related fetal lung tumors involving WNT pathway activation.

Conclusions:

  • Desmoid fibromatosis can be a rare manifestation of DICER1-related tumor predisposition.
  • A synergistic effect between germline DICER1 variants and somatic CTNNB1 mutations may drive WNT pathway activation in desmoid fibromatosis.
  • This finding expands the spectrum of tumors associated with DICER1-related disorders.